Member Exclusive

Study identifies potential epigenetic target for pancreatic cancer

Researchers at University of Texas M. D. Anderson Cancer Center (Houston, TX, United States) have identified arginine methyltransferase 1 as a potential therapeutic target for pancreatic ductal adenocarcinoma.

Go to the profile of Joe Martin
Apr 10, 2017

Please sign in or register for FREE to view this content

Register to EpigenomicsNet – the epigenetics and epigenomics network

EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...